Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
India's Mankind Licenses Entresto From Novartis, Acquires Panacea’s Brands
$1Bn Revenue Forecast For FY22
Feb 03 2022
•
By
Vibha Ravi
Mankind Pharma Strikes Two Deals • Source: Alamy
More from Business
More from Scrip